Silicon Valley Capital Partners
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1673633
SAN JOSE, CA
Position in TAK
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$722
New position
Shares Held
39
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Silicon Valley Capital Partners holds $21,325 across 5 Drug Manufacturers - Specialty & Generic names. TAK ranks #2 (3.4% of the industry book) .
All Filings in TAK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $722 | 39 | Shares | Sole | 2026-05-19 | |
| No filing history on record for this holder in this stock. | ||||||